Results 111 to 120 of about 1,208,573 (299)

Is vulnerability to cardiometabolic disease in Indians mediated by abdominal adiposity or higher body adiposity. [PDF]

open access: yes, 2014
BACKGROUND: Indians may be particularly vulnerable to cardiometabolic disease, potentially due to higher body fat for a given BMI, or a tendency towards depositing abdominal adiposity.
Davey-Smith, George   +12 more
core   +1 more source

Ultrasound‐Assisted Endoscopic Lesser Trochanter Resection for Ischiofemoral Impingement

open access: yesArthroscopy Techniques, EarlyView.
Abstract Ischiofemoral impingement is a rare cause of buttock pain resulting from narrowing of the space between the ischial tuberosity and the femoral lesser trochanter. Although most cases improve with conservative treatment, refractory cases may require surgical treatment.
Yuma Mitsuya   +5 more
wiley   +1 more source

Combined impact of sleep and obesity on female infertility in the NHANES 2017–2020

open access: yesBMC Women's Health
Background Sleep health and obesity may affect the risk of female infertility. However, few studies focused on the interaction of obesity and sleep health on the female infertility risk.
Zhe Wang   +4 more
doaj   +1 more source

Factors Associated with Abdominal Obesity in the Productive Age in Surabaya

open access: yesJurnal Berkala Epidemiologi, 2015
Obesity has become a public health and nutrition issues the world both developed countries and developing countries, including Indonesia. Abdominal obesity is one type of obesity where there is abdominal fat deposits as measured by waist circumference ...
Fani Kusteviani
doaj   +1 more source

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Metabolic liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, is a major cause of chronic liver dysfunction worldwide, creating an urgent need for effective treatments. This systematic literature review (SLR) and network meta‐analysis (NMA) systematically reviews and compares the efficacy and safety ...
Andrej Belančić   +8 more
wiley   +1 more source

Healthy Eating Index and abdominal obesity

open access: yesPublic Health Nutrition, 2009
AbstractObjectiveAlthough diet is a modifiable lifestyle factor to reduce abdominal obesity risk, the relationship between the Health Eating Index (HEI) and waist circumference (WC) has not been studied. The present study aimed to describe relationships between the HEI and abdominal obesity among adults.DesignSecondary data analysis of a cross ...
Desiree L, Tande   +2 more
openaire   +2 more sources

Clinical problems caused by obesity [PDF]

open access: yes, 2010
Over the past few decades the incidence of obesity has doubled worldwide and current estimates classify more than 1.5 billion adults as overweight and at least 500 million of them as clinically obese, with body mass index (BMI) over 25 kg/m2 and 30 kg ...
Weickert, Martin O., Kyrou, Ioannis
core  

Cumulative incidence of obesity and abdominal obesity.

open access: yes, 2016
(A) Cumulative incidence of obesity (BMI≥30mg/kg2); (B) cumulative incidence of abdominal obesity (WC>102cm men and WC>88cm women). Bold lines are the cumulative incidence; un-bold lines are 95% confidence intervals.
Luigi Ferrucci (150038)   +7 more
core   +1 more source

Exposure‐adjusted safety and efficacy of GLP‐I and GLP‐1/GIP receptor agonists compared with non‐GLP‐I for weight management and type 2 diabetes: Based on FDA medical and statistical reports of 34 280 safety and 36 312 efficacy subjects

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to contextualize glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists safety and efficacy regarding weight management (WM); we analysed Food and Drug Administration (FDA) Medical Reviews to analyse 14 medications using patient‐exposure year normalization and ...
Aishwarya Prasad   +4 more
wiley   +1 more source

Hypertension in obesity: A focus on individualized pharmacotherapy and the role of body composition, on behalf of the European Society of Hypertension Working Group on Diabetes and Metabolic Risk Factors and Working Group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Hypertension in obesity represents a major global health challenge, closely linked to the global epidemics of obesity, type 2 diabetes and metabolic dysfunction. Excess adiposity contributes to elevated blood pressure through multiple, interrelated mechanisms, including activation of the renin–angiotensin–aldosterone system, sympathetic nervous system ...
Christina Antza   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy